Intellia Therapeutics CEO John Leonard has, for the last couple years, found himself stuck in a financial Groundhog Day.
The Cool Down on MSN10h
Scientists are making headway in gene editing to unlock critical potential within trees: 'These findings ... lay the groundwork for further innovations'Scientists and engineers at North Carolina State University have discovered trees can be used to produce greener, ...
Kenya has joined the global movement in embracing genome editing (GEd) technology as a transformative tool to address food ...
Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...
Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...
Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.
Omega Therapeutics is halting work on its only clinical-stage candidate as part of a strategic refocus centered on three ...
StitchR makes it possible to deliver larger payloads with current vectors, expanding the list of diseases targetable by gene therapies.
However, the downside is that a complete blockade of this "editing office" also affects healthy cells, resulting in significant side effects of any spliceosome inhibitor developed so far. In an ...
By employing gene-editing techniques, researchers at Pivot Bio developed microbes that remain active in high-nitrogen conditions. The study introduces PROVEN® 40, Pivot Bio’s latest product featuring ...
Researchers used base and prime editing to uncover new EGFR gene mutations that affect cancer progression and drug resistance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback